Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer

Cancer statistics, 2016

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.1K citations · Full text

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

Elizabeth Allen, Arnaud Jabouille, Lee B. Rivera et al. · Science Translational Medicine · 2017 · 758 citations · Full text

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

Jeffrey J. Wallin, Johanna C. Bendell, Roel Funke et al. · Nature Communications · 2016 · 690 citations · Full text

Tumor Biology, Tumor Immunology, Cancer Immunosurveillance +14

Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer

Rajeev Shrimali, Zhiya Yu, Marc R. Theoret et al. · Cancer Research · 2010 · 667 citations · Full text

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

Heng Lin, Shuang Wei, Elaine M. Hurt et al. · Journal of Clinical Investigation · 2018 · 592 citations · Full text